INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579,567 | +50.7% | 31,262 | -10.1% | 0.02% | +46.7% |
| Q2 2023 | $384,483 | -9.6% | 34,767 | +9.7% | 0.02% | -11.8% |
| Q1 2023 | $425,442 | +8.1% | 31,682 | -0.4% | 0.02% | -15.0% |
| Q4 2022 | $393,440 | -2.4% | 31,806 | +10.1% | 0.02% | -4.8% |
| Q3 2022 | $403,000 | +16.1% | 28,890 | +14.8% | 0.02% | +16.7% |
| Q2 2022 | $347,000 | -18.2% | 25,160 | -3.4% | 0.02% | 0.0% |
| Q1 2022 | $424,000 | +27.3% | 26,033 | +27.2% | 0.02% | +28.6% |
| Q4 2021 | $333,000 | +12.5% | 20,468 | +2.6% | 0.01% | -6.7% |
| Q3 2021 | $296,000 | +8.4% | 19,953 | +45.8% | 0.02% | +7.1% |
| Q2 2021 | $273,000 | +875.0% | 13,686 | +1903.8% | 0.01% | +27.3% |
| Q3 2020 | $28,000 | – | 683 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |